Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
rare diseases
Marketing
Boehringer again rises up rare disease reputation rankings
Despite back-to-back jumps, the German drugmaker failed to crack the top three of the full table, which the same three companies occupied again.
Nick Paul Taylor
Aug 20, 2026 4:29am
Ultragenyx, after FDA speed bump, lands 1st gene therapy nod
Aug 19, 2026 10:33pm
CMI adopts orphan drug field with dedicated center of excellence
Aug 18, 2026 10:11am
Argenx preps next potential Vyvgart nod after ph. 3 win
Aug 17, 2026 10:52am
EU regulators offer post-mortem of Tavneos withdrawal decision
Aug 14, 2026 11:04am
Neurocrine's Prader-Willi med tied to possible safety concerns
Aug 13, 2026 9:40am
